Difference between revisions of "Biphasic hyalinizing psammomatous renal cell carcinoma"
Jump to navigation
Jump to search
| Line 5: | Line 5: | ||
| Caption = | | Caption = | ||
| Synonyms = | | Synonyms = | ||
| Micro = biphasic cytomorphology (small cells and large cells), hyaline stroma, [[psammoma bodies]] | | Micro = biphasic cytomorphology (small cells and large cells), hyaline stroma, [[psammoma bodies]] | ||
| Subtypes = | | Subtypes = | ||
| LMDDx = [[TFEB renal cell carcinoma]], [[papillary renal cell carcinoma]], [[FH-deficient renal cell carcinoma]] | | LMDDx = [[TFEB renal cell carcinoma]], [[papillary renal cell carcinoma]], [[FH-deficient renal cell carcinoma]] | ||
Latest revision as of 17:57, 25 March 2024
| Biphasic hyalinizing psammomatous renal cell carcinoma | |
|---|---|
| Diagnosis in short | |
|
| |
| LM | biphasic cytomorphology (small cells and large cells), hyaline stroma, psammoma bodies |
| LM DDx | TFEB renal cell carcinoma, papillary renal cell carcinoma, FH-deficient renal cell carcinoma |
| IHC | merlin loss of staining, HNF-1beta +ve, PAX8 +ve, CK7 +ve, EMA +ve, AMACR +ve, WT1 -ve, Melan A -ve, HMB-45 -ve, GATA3 -ve |
| Molecular | neurofibromin 2 mutations |
Biphasic hyalinizing psammomatous renal cell carcinoma, abbreviated BHP RCC, is a rare type of renal cell carcinoma with mutations in neurofibromin 2.[1]
It is not recognized as a subtype of RCC by the WHO of 2022.[2]
General
- Evolving entity.
- Very rare.
- Prevalence: male > female.
Microscopic
Features:[1]
- Biphasic cytomorphology:
- Small cells.
- Large cells.
- Hyaline stroma.
- Psammoma bodies.
DDx:
IHC
Features:[1]
- HNF-1beta +ve
- PAX8 +ve
- CK7 +ve
- EMA +ve.
- AMACR +ve.
- WT1 -ve
- Melan A -ve.
- HMB-45 -ve.
- GATA3 -ve.
- Chromogranin A -ve.
- Synaptophysin -ve.
- FH normal.
- SDHB normal.
Others:
- Merlin - loss of staining (12 of 13 cases[2]).
Molecular
- Neurofibromin 2 (NF2) gene mutations.[2]
See also
References
- ↑ 1.0 1.1 1.2 Argani P, Reuter VE, Eble JN, Vlatkovic L, Yaskiv O, Swanson D, Dickson BC, Antonescu CR, Matoso A, Gagan J, Palsgrove DN (July 2020). "Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma (BHP RCC): A Distinctive Neoplasm Associated With Somatic NF2 Mutations". Am J Surg Pathol 44 (7): 901–916. doi:10.1097/PAS.0000000000001467. PMC 7350624. PMID 32217839. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350624/.
- ↑ 2.0 2.1 2.2 Collins K, Hwang M, Antic T, Paintal A, Argani P, Matoso A, Gopinath A, Baskovich B, Mehra R, Williamson SR, Idrees MT, Barletta JA, Anderson WJ, Hirsch MS, Hornick JL, Acosta AM (November 2022). "Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinoma". Histopathology 81 (5): 577–586. doi:10.1111/his.14731. PMID 35971742.